Luiza Akria

568 total citations
30 papers, 296 citations indexed

About

Luiza Akria is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Luiza Akria has authored 30 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Luiza Akria's work include Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Luiza Akria is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Luiza Akria collaborates with scholars based in Israel, Australia and Spain. Luiza Akria's co-authors include Andrei Braester, Eldad J. Dann, Tsila Zuckerman, Najib Dally, Wojciech Jurczak, Peijuan Zhu, I. Oren, Angela Zubel, Juliana Pereira and H. Sprecher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luiza Akria

30 papers receiving 292 citations

Peers

Luiza Akria
M Berger United States
Stefania Cheli Italy
Ashwini Shewade United States
Ehsan Zaboli Iran
D. Pei United States
Rajani Kaimal United States
Jessica Hardin United States
Ghasem Janbabaei Iran
Hussein Mahagna Israel
Nancy Wei United States
M Berger United States
Luiza Akria
Citations per year, relative to Luiza Akria Luiza Akria (= 1×) peers M Berger

Countries citing papers authored by Luiza Akria

Since Specialization
Citations

This map shows the geographic impact of Luiza Akria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luiza Akria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luiza Akria more than expected).

Fields of papers citing papers by Luiza Akria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luiza Akria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luiza Akria. The network helps show where Luiza Akria may publish in the future.

Co-authorship network of co-authors of Luiza Akria

This figure shows the co-authorship network connecting the top 25 collaborators of Luiza Akria. A scholar is included among the top collaborators of Luiza Akria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luiza Akria. Luiza Akria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akria, Luiza, et al.. (2025). Case Report: Anti-platelet factor 4 -mediated immunothrombosis in a patient with ANCA vasculitis – a shared mechanism of NETosis. Frontiers in Immunology. 16. 1567999–1567999. 1 indexed citations
2.
Braester, Andrei, et al.. (2023). The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis. International Journal of Laboratory Hematology. 46(1). 58–62. 4 indexed citations
3.
Wolf, Maya Frank, et al.. (2023). Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature. Taiwanese Journal of Obstetrics and Gynecology. 62(5). 761–764. 4 indexed citations
4.
Aviram, Joshua, Gil M. Lewitus, Idan Cohen, et al.. (2022). The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients. SHILAP Revista de lepidopterología. 3. 861037–861037. 18 indexed citations
5.
Barki‐Harrington, Liza, Orna Baron‐Epel, Adir Shaulov, et al.. (2021). Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy. Palliative Medicine. 35(5). 927–932. 6 indexed citations
6.
Braester, Andrei, et al.. (2021). Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse. Acta Haematologica. 145(1). 5–8. 4 indexed citations
7.
Braester, Andrei, et al.. (2020). Blood Myths and Ethnic–Cultural Background as Impediments in Patient Blood Management Education. Journal of Religion and Health. 59(6). 2918–2927. 1 indexed citations
8.
Zuckerman, Tsila, Ron Ram, Luiza Akria, et al.. (2019). BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study. Blood Advances. 3(22). 3740–3749. 10 indexed citations
9.
Azoulay, David, et al.. (2018). Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation. Experimental Hematology. 63. 17–21.e1. 8 indexed citations
10.
Akria, Luiza, et al.. (2017). Physicians’ lack of knowledge - a possible reason for red blood cell transfusion overuse?. Israel Journal of Health Policy Research. 6(1). 49–49. 11 indexed citations
11.
Jurczak, Wojciech, Nelson Castro, Juliana Pereira, et al.. (2017). Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study. Annals of Oncology. 28. v355–v355. 3 indexed citations
12.
Dann, Eldad J., Osnat Bairey, Rachel Bar‐Shalom, et al.. (2017). Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients. British Journal of Haematology. 178(5). 709–718. 26 indexed citations
13.
14.
15.
16.
Braester, Andrei, et al.. (2012). Alemtuzumab and Myelodysplasia: A Story of Love and Hate (Possible Alemtuzumab-Induced Myelodysplastic Changes). Acta Haematologica. 129(3). 185–186. 1 indexed citations
17.
18.
19.
20.
Akria, Luiza, et al.. (2006). Granulocytic sarcoma with pulmonary involvement. American Journal of Hematology. 82(3). 222–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Berger Breakdown of academic impact, for papers by Stefania Cheli Breakdown of academic impact, for papers by Ashwini Shewade Breakdown of academic impact, for papers by Ehsan Zaboli Breakdown of academic impact, for papers by D. Pei Breakdown of academic impact, for papers by Rajani Kaimal Breakdown of academic impact, for papers by Jessica Hardin Breakdown of academic impact, for papers by Ghasem Janbabaei Breakdown of academic impact, for papers by Hussein Mahagna Breakdown of academic impact, for papers by Nancy Wei
Rankless by CCL
2026